NASDAQ : CVRX
CVRx, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 1.425 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 37.96M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 37.56M |
| Enterprise Value | 32.37M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 26.64M |
| Shares Outstanding | 26.64M |
| Shares Change (YoY) | +5.82% |
| Shares Change (QoQ) | +0.61% |
| Owned by Insiders (%) | 1.67% |
| Owned by Institutions (%) | 43.66% |
| Float | 18.31M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.61 |
| Forward PS | 0.62 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 1.88 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 0.53 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 8.04 |
| Quick Ratio | 6.65 |
| Debt / Equity | 2.98 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -8.07 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -133.44% |
| Return on Assets (ROA) | -28.70% |
| Return on Invested Capital (ROIC) | -32.37% |
| Return on Capital Employed (ROCE) | -59.93% |
| Weighted Average Cost of Capital (WACC) | 8.19% |
| Revenue Per Employee | $274,386 |
| Profits Per Employee | -$233,040 |
| Employee Count | 223 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 0.65 |
Taxes
| Measure | Value |
|---|
| Income Tax | -6,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.77 |
| 52-Week Price Change | -86.96% |
| 50-Day Moving Average | 2.26 |
| 200-Day Moving Average | 5.28 |
| Relative Strength Index (RSI) | 32.04 |
| Average Volume (20 Days) | 446,792 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.14M |
| Short Previous Month | 1.98M |
| Short % of Shares Out | 8.02% |
| Short % of Float | 11.67% |
| Short Ratio (days to cover) | 2.84 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 61.19M |
| Gross Profit | 53.18M |
| Operating Income | -48.64M |
| Pretax Income | -51.97M |
| Net Income | -51.97M |
| EBITDA | -47.84M |
| EBIT | -48.64M |
| Loss Per Share | -$1.97 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 64.59M |
| Total Debt | 59.39M |
| Net Cash | 5.20M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 19.95M |
| Book Value Per Share | 0.75 |
| Working Capital | 78.36M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -40.46M |
| Capital Expenditures | -597,000 |
| Depreciation & Amortization | 793,000 |
| Net Borrowing | 10.00M |
| Free Cash Flow | -41.05M |
| FCF Per Share | -$1.54 |
Margins
| Measure | Value |
|---|
| Gross Margin | 86.92% |
| Operating Margin | -79.49% |
| Pretax Margin | -84.94% |
| Profit Margin | -84.93% |
| EBITDA Margin | -78.19% |
| EBIT Margin | -79.49% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -5.82% |
| Shareholder Yield | -5.82% |
| Earnings Yield | -140.06% |
| FCF Yield | -109.29% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $4.58 |
| Price Target Difference | 224.82% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 10.93% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -7.77 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |